ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,429Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 79

$532K Total Retail Price of All Prescriptions

Rank: 22 out of 79

598 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 598 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 7,661 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 564 539 1 3
HYDROCODONE-ACETAMINOPHEN 482 291 S3 2 5
LISINOPRIL 362 283 3 2
LEVOTHYROXINE SODIUM 345 290 4 1
OMEPRAZOLE 290 247 5 7
TRAZODONE HCL 270 242 6 19
FUROSEMIDE 241 190 7 4
AMLODIPINE BESYLATE 237 215 8 6
SERTRALINE HCL 231 218 9 16
POTASSIUM CHLORIDE 223 187 10 11
METFORMIN HCL 214 171 11 13
HYDROCHLOROTHIAZIDE 176 142 12 22
ATORVASTATIN CALCIUM 139 122 13 30
ALENDRONATE SODIUM 134 134 14 32
GABAPENTIN 132 77 15 12
METOPROLOL SUCCINATE 130 112 16 23
DIOVAN HCT 116 103 17 155
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 96 18 53
NEXIUM 99 57 19 34
ATENOLOL 97 96 20 45
METOPROLOL TARTRATE 96 74 21 10
GLIMEPIRIDE 94 75 22 77
LOVASTATIN 90 72 23 102
LOSARTAN-HYDROCHLOROTHIAZIDE 89 80 24 111
FLUTICASONE PROPIONATE 84 67 25 47
PAROXETINE HCL 79 51 26 87
WARFARIN SODIUM 76 63 27 14
ROPINIROLE HCL 75 54 28 109
CITALOPRAM HBR 74 53 29 18
ZOLPIDEM TARTRATE 73 47 30 28
AZITHROMYCIN 71 63 31 75
PREDNISONE 65 44 32 54
CLOPIDOGREL 65 56 32 31
CYMBALTA 64 59 34 27
DIOVAN 63 61 35 56
TRAMADOL HCL 63 28 35 17
RAMIPRIL 62 61 37 47
CARVEDILOL 60 53 38 21
PRAVASTATIN SODIUM 58 48 39 38
TAMSULOSIN HCL 57 45 40 36
NAMENDA 52 52 41 9
TRIAMTERENE-HCTZ 51 44 42 105
LOSARTAN POTASSIUM 50 46 43 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.